In the mid cap space there are a good number of shares that have the potential to grow strongly over the next decade, potentially generating market-beating returns for shareholders.
Three that could be great options for long-term focused investors are listed below. Here's why they are highly rated:
Bravura Solutions Ltd (ASX: BVS)
The first mid cap ASX share to look at is Bravura. It is a leading provider of software solutions for the wealth management and funds administration industries. Bravura has a portfolio of solutions that are both high quality and have significant market opportunities. This is particularly the case for the Sonata wealth management platform, which is used by a number of large financial institutions.
Earlier this week, Goldman Sachs retained its buy rating and lifted its price target on the company's shares to $3.90.
Collins Foods Ltd (ASX: CKF)
Another mid cap ASX share to consider buying is Collins Foods. It is one of the largest quick service restaurant operators in the ANZ region. It currently operates 251 KFC stores in Australia, 45 KFC stores in Europe, and 16 Taco Bell across Queensland and Victoria. Positively, management still sees plenty of room to expand its network in the future, particularly in the underpenetrated European market. Combined with the continued popularity of its brands, this should be supportive of further earnings and dividend growth long into the future.
UBS currently has a buy rating and $11.65 price target on its shares.
Kogan.com Ltd (ASX: KGN)
A final mid cap ASX share to consider is Kogan. It is one of Australia's leading ecommerce companies and has been growing at an explosive rate over the last 12 months. And while its growth is now slowing as tailwinds ease, its long term potential remains as bright as ever. This is thanks to the ongoing shift to online shopping and its strong market position.
One broker that believes that a recent pullback in the Kogan share price is a buying opportunity is Credit Suisse. Last week it retained its outperform rating and trimmed its price target to $17.93. This is materially higher than where it trades today.
